$25 Early Bird Special through February 1, 2025; $35 beginning February 2
Following the 2024 Lymphatic Summit, the world has experienced an exciting year of advances in lymphatic science, clinical care, and research funding. This year’s event, Lymphatic Horizons: A 2025 Update, will feature an overview of lymphatic horizons, featuring insights into lymphedema therapeutics, biomedical technology, the veno-lymphatic connection, the role of lymphatics in brain diseases, and many additional, exciting topics.
Up to 10 million Americans are estimated to be living with lymphedema (LE) and there are an additional 17 million women in America estimated to have lipedema (LI). The World Health Organization projects up to 250 million people with LE worldwide. Nevertheless, lymphatic patients still struggle to find physicians who are prepared to undertake their necessary medical care. Upon completion of this summit, participants will be better equipped to provide state-of-the-art lymphatic care.
Stanley G. Rockson, MD
Summit Organizer Chief of Consultative Cardiology, Allan and Tina Neill Professor of Lymphatic Research and Medicine Professor of Medicine, Director, Center for Lymphatic and Venous Disorders Stanford University School of Medicine, Falk Cardiovascular Research Center
SPEAKERS
Jean-Paul Belgrado, PhD, Université Libre de Bruxelles, Belgium
Kathleen Caron, PhD, University of North Carolina at Chapel Hill, NC
Brandon Dixon, PhD, Georgia Tech, Atlanta, GA
Barbara Garmy-Susini, PhD, Institute of Metabolic and Cardiovascular Diseases (I2MC) of Toulouse, France
Sergio Gianesini, MD, PhD, FACS, University of Ferrara, Italy
Max Itkin, MD, Children’s Hospital of Philadelphia, PA
Jonathan Kipnis, PhD, Washington University, St. Louis, MO
Pia Ostergard, Professor, St. George’s University Hospital, London, UK
Tim Padera, PhD, Harvard Medical School, Boston, MA
Willam Repicci, CEO and President, LE&RN, New York, NY
Carrie Shawber, PhD, Columbia University, New York, NY
Kimberley Steele, MD, PhD, ARPA-H, Washington, DC
Stanley G. Rockson, MD, Center for Lymphatic and Venous Disorders, Stanford University School of Medicine,Palo Alto, CA
Andrzej Szuba, MD, PhD, Wroclaw Medical University, Poland
Miika Vikkula, MD, PhD, de Duve Institute, Brussels, Belgium
AGENDA
Welcome and Introductions
Stanley G. Rockson, Stanford University and LE&RN, Palo Alto, CA
Willam Repicci, CEO and President, LE&RN, New York, NY
Apelin-VEGF-C mRNA Delivery as Therapeutic for the Treatment of Secondary Lymphedema; Barbara Garmy-Susini, Institute of Metabolic and Cardiovascular Diseases (I2MC) of Toulouse, France
Bioengineered Materials to Support Lymphatic Regrowth; Brandon Dixon, Georgia Tech, Atlanta, GA
Brain Drainage and Neurological Eiseases; Jonathan Kipnis, Washington University, St. Louis, MO
The Central Lymphatic System at a Crossroads: Embolization or Decompression?; Max Itkin, Children’s Hospital of Philadelphia, PA
Congenital Lymphatics Anomalies: Genetics and Therapeutic Interventions; Carrie Shawber, Columbia University, New York, NY
Drug Therapy for Lymphedema: A Progress Report; Stanley Rockson, Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Palo Alto, CA
From Heterogeneous Pathophysiology Towards Targeted Treatments for Lymphatic Anomalies; Miika Vikkula, de Duve Institute, Brussels, Belgium
Lymphatics in the Pathophysiology of Migraine Pain; Kathleen Caron, University of North Carolina at Chapel Hill, NC
Lymphatic Opportunities Through ARPA-H; Kimberly Steele, ARPA-H, Washington, DC
Lymphofluoroscopy for In Vivo Imaging Physiological and Pathophysiological Implications; Jean-Paul Belgrado, Université Libre de Bruxelles, Belgium
Mechanisms of Lymphatic Dysfunction in Disease; Tim Padera, Harvard Medical School, Boston, MA
Pathophysiology of the Lymphatic System: Update 2025; Andrzej Szuba, Wroclaw Medical University, Poland
Update On the Genetics of Lymphoedema and Lipoedema at St George's Hospital, London; Pia Ostergaard, St. George’s University Hospital, London, UK
Veno-lymphatic Synergy: The v-REGISTRY Global Project; Sergio Gianesini, University of Ferrara, Italy